{
  "id": 16197375,
  "title": "Kerala to retain generic SMA treatment despite objections",
  "url": "https://urgent.news/2026/10/23/kerala-to-retain-generic-sma-treatment-despite-objections",
  "topic": "world",
  "section": "World",
  "published": "2026-10-23T14:18:34.000Z",
  "source": {
    "name": "Arabian Post",
    "slug": "arabian-post",
    "url": "https://thearabianpost.com/kerala-to-retain-generic-sma-treatment-despite-objections/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Kerala Health Minister K Muraleedharan has reaffirmed the government's decision to continue administering a cheaper generic formulation of risdiplam to children with spinal muscular atrophy (SMA), rejecting demands to suspend its use amid mounting concerns over safety, procurement procedures and medicine labelling. Th… The article Kerala to retain generic SMA treatment despite objections appeared…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}